Search

Your search keyword '"Brown, Gordon A."' showing total 4,617 results

Search Constraints

Start Over You searched for: Author "Brown, Gordon A." Remove constraint Author: "Brown, Gordon A."
4,617 results on '"Brown, Gordon A."'

Search Results

2. Income Inequality and Status Seeking: A Study Using Large-Scale Human Mobility Data

13. Quantum Webs of Type Q

16. Experts discuss the impact of PSMA-PET imaging in prostate cancer

19. Comparison of prostate-specific antigen (PSA) response in patients with de novo metastatic castration-sensitive prostate cancer (mCSPC) treated with apalutamide (APA) vs abiraterone acetate (ABI): A real-world (RW) causal analysis.

20. Real-world (RW) comparison of prostate-specific antigen (PSA) response in patients with de novo metastatic castration-sensitive prostate cancer (mCSPC) treated with apalutamide (APA) versus enzalutamide (ENZ).

21. Apa-RP: Multicenter phase 2 study of apalutamide (Apa) and androgen deprivation therapy (ADT) for the treatment of high-risk localized prostate cancer (HR LPC) following radical prostatectomy (RP)—Results in Black and non-Black patients (pts).

22. PD30-09 RESPONSE TO PRIMARY CHEMOABLATION WITH UGN-102 IN PATIENTS WITH NEW OR RECURRENT LG IR NMIBC: POST-HOC ANALYSIS OF THE ATLAS TRIAL

24. PD48-01 EFFICACY OF NADOFARAGENE FIRADENOVEC-VNCG FOR PATIENTS WITH BACILLUS CALMETTE-GUÉRIN-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER: FINAL RESULTS FROM A PHASE 3 TRIAL

25. Webs for permutation supermodules of type Q

26. Webs of type Q

27. CARD9+ microglia promote antifungal immunity via IL-1β- and CXCL1-mediated neutrophil recruitment.

28. Immune cells fold and damage fungal hyphae

29. Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing

32. TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing

34. EFFICACY OF INTRAVESICAL NADOFARAGENE FIRADENOVEC FOR PATIENTS WITH BCG-UNRESPONSIVE CARCINOMA IN SITU OF THE BLADDER: 36-MONTH FOLLOW-UP FROM A PHASE 3 TRIAL

35. TREATMENT OF LOW-GRADE INTERMEDIATE-RISK NONMUSCLE-INVASIVE BLADDER CANCER WITH UGN-102 ± TRANSURETHRAL RESECTION OF BLADDER TUMOR (TURBT) COMPARED TO TURBT MONOTHERAPY: THE PHASE 3 ATLAS TRIAL

36. A CO 2 sensing module modulates β-1,3-glucan exposure in Candida albicans

37. The pathogenesis of experimental Emergomycosis in mice

40. C-Type Lectin Receptors in Antifungal Immunity

41. Signaling C-Type Lectin Receptors in Antifungal Immunity

42. PAMPs of the Fungal Cell Wall and Mammalian PRRs

44. A theory-informed approach to developing visually mediated interventions to change behaviour using an asthma and physical activity intervention exemplar

45. Efficacy of Professional Development Schools in Developing Countries: Panama

48. Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial

50. A spatially resolved surface kinetic model for forsterite dissolution

Catalog

Books, media, physical & digital resources